M&T Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.6K | Buy |
80
+2
| +3% | +$444 | ﹤0.01% | 1706 |
|
|
2025
Q4 | $15.4K | Hold |
78
| – | – | ﹤0.01% | 1680 |
|
|
2025
Q3 | $70.8K | Buy |
78
+9
| +13% | +$1.83K | ﹤0.01% | 1438 |
|
|
2025
Q2 | $3.17K | Sell |
69
-20
| -22% | -$3.72K | ﹤0.01% | 1552 |
|
|
2025
Q1 | $12K | Buy |
89
+2
| +2% | +$389 | ﹤0.01% | 1517 |
|
|
2024
Q4 | $15.5K | Sell |
87
-13
| -13% | -$2.39K | ﹤0.01% | 1599 |
|
|
2024
Q3 | $48.5K | Buy |
100
+18
| +22% | +$3.36K | ﹤0.01% | 1587 |
|
|
2024
Q2 | $25.4K | Sell |
82
-14
| -15% | -$2.32K | ﹤0.01% | 1556 |
|
|
2024
Q1 | $34.8K | Buy |
96
+18
| +23% | +$3.1K | ﹤0.01% | 1578 |
|
|
2023
Q4 | $3.98K | Buy |
78
+15
| +24% | +$2.19K | ﹤0.01% | 1611 |
|
|
2023
Q3 | $756 | Hold |
63
| – | – | ﹤0.01% | 1584 |
|
|
2023
Q2 | $2.14K | Sell |
63
-50
| -44% | -$7.33K | ﹤0.01% | 1620 |
|
|
2023
Q1 | $101K | Buy |
+113
| New | +$17.3K | ﹤0.01% | 1559 |
|
|
2022
Q4 | – | Sell |
-69
| Closed | -$46K | – | 1594 |
|
|
2022
Q3 | $46K | Hold |
69
| – | – | ﹤0.01% | 1539 |
|
|
2022
Q2 | $152K | Hold |
69
| – | – | ﹤0.01% | 1419 |
|
|
2022
Q1 | $200K | Buy |
69
+30
| +77% | +$4.36K | ﹤0.01% | 1383 |
|
|
2021
Q4 | $33K | Buy |
39
+10
| +34% | +$1.18K | ﹤0.01% | 1539 |
|
|
2021
Q3 | $2K | Hold |
29
| – | – | ﹤0.01% | 1560 |
|
|
2021
Q2 | $1K | Hold |
29
| – | – | ﹤0.01% | 1584 |
|
|
2021
Q1 | $1K | Hold |
29
| – | – | ﹤0.01% | 1547 |
|
|
2020
Q4 | $4K | Buy |
+29
| New | +$2.79K | ﹤0.01% | 1660 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | -$6K | – | 1596 |
|
|
2020
Q2 | $6K | Hold |
24
| – | – | ﹤0.01% | 1545 |
|
|
2020
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 1539 |
|
|
2019
Q4 | $5K | Buy |
+24
| New | +$1.99K | ﹤0.01% | 1382 |
|
|
2018
Q3 | – | Sell |
-10
| Closed | -$19K | – | 1559 |
|
|
2018
Q2 | $19K | Hold |
10
| – | – | ﹤0.01% | 1503 |
|
|
2018
Q1 | $23K | Sell |
10
-2
| -17% | -$220 | ﹤0.01% | 1515 |
|
|
2017
Q4 | $26K | Sell |
12
-9
| -43% | -$848 | ﹤0.01% | 1537 |
|
|
2017
Q3 | $35K | Hold |
21
| – | – | ﹤0.01% | 1520 |
|
|
2017
Q2 | $7K | Sell |
21
-2
| -9% | -$134 | ﹤0.01% | 1563 |
|
|
2017
Q1 | $2K | Sell |
23
-1
| -4% | -$63 | ﹤0.01% | 1626 |
|
|
2016
Q4 | $2K | Buy |
24
+3
| +14% | +$183 | ﹤0.01% | 1668 |
|
|
2016
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 1687 |
|
|
2016
Q2 | $2K | Sell |
21
-2,079
| -99% | -$127K | ﹤0.01% | 1648 |
|
|
2016
Q1 | $1K | Sell |
2,100
-400
| -16% | -$22.3K | ﹤0.01% | 1701 |
|
|
2015
Q4 | $3K | Buy |
2,500
+1,500
| +150% | +$86.4K | ﹤0.01% | 1705 |
|
|
2015
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1783 |
|
|
2015
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 2023 |
|
|
2015
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 2021 |
|
|
2014
Q4 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 2039 |
|
|
2014
Q3 | $4K | Buy |
+1,000
| New | +$55.5K | ﹤0.01% | 2223 |
|
Other funds holding ABBV
VCM
VPM
M&T Bank's ABBV Position: Q1 2026 in Review
M&T Bank reduced its AbbVie (ABBV) stake by 3.4% in Q1 2026, selling an estimated $7.38M and leaving 941,726 shares worth $205M. The position accounts for 0.7% of the portfolio, ranked #27.
M&T Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $223M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- M&T Bank held 941,726 shares of AbbVie worth $205M as of Q1 2026.
- M&T Bank sold 33,261 AbbVie shares in Q1 2026, an estimated $7.38M.
- AbbVie made up 0.7% of M&T Bank's portfolio in Q1 2026, its #27 holding.
- M&T Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- M&T Bank's AbbVie position peaked at $223M in Q4 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.